OBJECTIVES: To identify factors associated with herpes simplex virus type 2 (HSV-2) infection among men aged 18-24 in Kisumu, Kenya. METHODS: Baseline data from a randomised trial of male circumcision were analysed. Participants were interviewed for sociodemographic and behavioural risks. The outcome was HSV-2 by antibody status. Risk factors were considered singly and in combination through logistic regression models. RESULTS: Among 2771 uncircumcised men, 766 (27.6%; 95% confidence interval (CI) 26.0% to 29.3%) tested antibody positive for HSV-2. The median age at first sex was 16 years, and the median number of lifetime sexual partners was four. HSV-2seroprevalence increased from 19% among 18-year-olds to 43% among 24-year-olds (p<0.001). In multivariable analysis, statistically significant risks for infection were increasing age (adjusted odds ratio (AOR) = 1.22-2.58), being married or having a live-in female partner (AOR = 1.80; 95% CI 1.28 to 2.53), preferring "dry" sex (AOR = 1.39; 95% CI 1.14 to 1.69), reported penile cuts or abrasions during sex (AOR = 1.58; 95% CI 1.32 to 1.91), increasing lifetime sex partners (multiple response categories; AORs ranging from 1.65 to 1.97), and non-student occupation (multiple response categories; AORs ranging from 1.44 to 1.93). Risk decreased with reported condom used at last sex (AOR = 0.82; 95% CI 0.68 to 0.99). CONCLUSION: Primary prevention efforts should be initiated at an early age. The same behavioural interventions used currently for HIV prevention-abstinence, reducing the number of sex partners and increasing condom use-should be effective for HSV-2 prevention.
RCT Entities:
OBJECTIVES: To identify factors associated with herpes simplex virus type 2 (HSV-2) infection among men aged 18-24 in Kisumu, Kenya. METHODS: Baseline data from a randomised trial of male circumcision were analysed. Participants were interviewed for sociodemographic and behavioural risks. The outcome was HSV-2 by antibody status. Risk factors were considered singly and in combination through logistic regression models. RESULTS: Among 2771 uncircumcised men, 766 (27.6%; 95% confidence interval (CI) 26.0% to 29.3%) tested antibody positive for HSV-2. The median age at first sex was 16 years, and the median number of lifetime sexual partners was four. HSV-2 seroprevalence increased from 19% among 18-year-olds to 43% among 24-year-olds (p<0.001). In multivariable analysis, statistically significant risks for infection were increasing age (adjusted odds ratio (AOR) = 1.22-2.58), being married or having a live-in female partner (AOR = 1.80; 95% CI 1.28 to 2.53), preferring "dry" sex (AOR = 1.39; 95% CI 1.14 to 1.69), reported penile cuts or abrasions during sex (AOR = 1.58; 95% CI 1.32 to 1.91), increasing lifetime sex partners (multiple response categories; AORs ranging from 1.65 to 1.97), and non-student occupation (multiple response categories; AORs ranging from 1.44 to 1.93). Risk decreased with reported condom used at last sex (AOR = 0.82; 95% CI 0.68 to 0.99). CONCLUSION: Primary prevention efforts should be initiated at an early age. The same behavioural interventions used currently for HIV prevention-abstinence, reducing the number of sex partners and increasing condom use-should be effective for HSV-2 prevention.
Authors: H A Weiss; A Buvé; N J Robinson; E Van Dyck; M Kahindo; S Anagonou; R Musonda; L Zekeng; L Morison; M Caraël; M Laga; R J Hayes Journal: AIDS Date: 2001-08 Impact factor: 4.177
Authors: María del Mar Pujades Rodríguez; Angela Obasi; Frank Mosha; Jim Todd; David Brown; John Changalucha; David Mabey; David Ross; Heiner Grosskurth; Richard Hayes Journal: AIDS Date: 2002-02-15 Impact factor: 4.177
Authors: Ronald H Gray; X Li; Maria J Wawer; David Serwadda; Nelson K Sewankambo; Fred Wabwire-Mangen; Tom Lutalo; Noah Kiwanuka; Godfrey Kigozi; Fred Nalugoda; Mary P Meehan; Merlin Robb; Thomas C Quinn Journal: J Infect Dis Date: 2004-03-15 Impact factor: 5.226
Authors: Haile Selassie Okuku; Eduard J Sanders; Joyce Nyiro; Caroline Ngetsa; Eric Ohuma; R Scott McClelland; Matthew A Price; Susan M Graham Journal: Sex Transm Dis Date: 2011-09 Impact factor: 2.830
Authors: Emily T Martin; Elizabeth Krantz; Sami L Gottlieb; Amalia S Magaret; Andria Langenberg; Lawrence Stanberry; Mary Kamb; Anna Wald Journal: Arch Intern Med Date: 2009-07-13
Authors: John N Krieger; Supriya D Mehta; Robert C Bailey; Kawango Agot; Jeckoniah O Ndinya-Achola; Corette Parker; Stephen Moses Journal: J Sex Med Date: 2008-08-28 Impact factor: 3.802
Authors: Aaron A R Tobian; Blake Charvat; Victor Ssempijja; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Boaz Iga; Oliver Laeyendecker; Melissa Riedesel; Amy Oliver; Michael Z Chen; Steven J Reynolds; Maria J Wawer; Ronald H Gray; Thomas C Quinn Journal: J Infect Dis Date: 2009-04-01 Impact factor: 5.226
Authors: Aaron A R Tobian; Victor Ssempijja; Godfrey Kigozi; Amy E Oliver; David Serwadda; Frederick Makumbi; Frederick K Nalugoda; Boaz Iga; Steven J Reynolds; Maria J Wawer; Thomas C Quinn; Ronald H Gray Journal: AIDS Date: 2009-07-31 Impact factor: 4.177
Authors: Sheetal Patel; Martin T Schechter; Nelson K Sewankambo; Stella Atim; Noah Kiwanuka; Patricia M Spittal Journal: PLoS One Date: 2014-02-28 Impact factor: 3.240